rAd5-EBV-LMP2 vaccine

治疗性重组腺病毒5型EB病毒潜伏膜抗原2（Ad-LMP2）疫苗

Report date: 2026/02/06 09:27:23

Base Information

Drug NamerAd5-EBV-LMP2 vaccine

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNasopharyngeal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaDiscontinued

Originator CompaniesYabao Pharmaceutical Group Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesYabao Pharmaceutical Group Co Ltd

Active IndicationsN/A

Inactive IndicationsNasopharyngeal Neoplasms

Other Information

ATC CodeN/A